RaDVaC Data Explorer
Antiviral database
Virus Taxonomy
← Back to Dashboard
Molnupiravir
Nucleoside analog
2D Structure
Loading structure...
3D Structure
Loading 3D structure...
Chemical Identifiers
SMILES:
CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O
InChI Key:
HTNPEHXGEKVIHG-QCNRFFRDSA-N
ClinicalTrials.gov
PubMed
Clinical Development by Virus
5
Severe acute respiratory syndrome-related coronavirus
SARS-CoV-2
Target: Viral RNA pol
FDA approved
Preclinical
Phase 2
positive
Phase 3
positive
Approved
FDA
Japan
Russia
Approval ref: AntiviralDb
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
NCT04405570
Influenza A virus
FLUAV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PMID:31645453
Influenza B virus
FLUBV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PMID:31645453
Severe acute respiratory syndrome-related coronavirus
SARS-CoV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PMID:32253226
Middle East respiratory syndrome-related coronavirus
MERS-CoV
Target: Viral RNA pol
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approval ref (kegg.jp)
Approval ref (pmda.go.jp)
PMID:32253226